Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment
- PMID: 19656004
- DOI: 10.3109/03639040903099751
Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment
Abstract
Background: Mucoadhesive drug delivery is a promising strategy to overcome ocular biopharmaceutical constraints.
Objective and methods: Ciprofloxacin HCl-loaded reverse phase evaporation liposomes were coated with different concentrations and molecular weights of mucoadhesive biocompatible chitosan polymer to form chitosomes. This colloidal mucoadhesive system was evaluated in vitro and in vivo with respect to deliver the antibiotic to ocular surface.
Results and conclusion: The results obtained pointed out that liposome coating process resulted in entrapment efficiency reduction and higher chitosan concentration, and molecular weight showed a more pronounced effect. No morphological differences between coated and uncoated liposomes were observed. Diffusion was the drug release mechanism from chitosomes. Concerning rheological behavior, pseudoplastic flow was characteristic to the prepared chitosomal dispersions. In addition, chitosan coating improved the ocular permeation of ciprofloxacin HCl. Microbiologically; this formulated system enhanced antimicrobial activity of ciprofloxacin HCl against both Gram-positive and Gram-negative bacteria. Moreover, this mucoadhesive system was able to inhibit the growth of Pseudomonas aeruginosa in rabbits' eyes for 24 hours when compared to the marketed preparation. In vivo bacterial conjunctivitis model elucidated that symptoms were controlled by the prolonged release formulation such as that done by the marketed product.
Similar articles
-
Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes.Pharm Dev Technol. 2011 Feb;16(1):44-56. doi: 10.3109/10837450903479988. Epub 2009 Dec 21. Pharm Dev Technol. 2011. PMID: 20025433
-
Chitosomes as drug delivery systems for C-phycocyanin: preparation and characterization.Int J Pharm. 2010 Jun 15;392(1-2):92-100. doi: 10.1016/j.ijpharm.2010.03.038. Epub 2010 Mar 23. Int J Pharm. 2010. PMID: 20338230
-
Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery.Int J Pharm. 2009 Sep 8;379(1):131-8. doi: 10.1016/j.ijpharm.2009.06.020. Epub 2009 Jun 25. Int J Pharm. 2009. PMID: 19559775
-
Chitosan-based drug delivery systems.Eur J Pharm Biopharm. 2012 Aug;81(3):463-9. doi: 10.1016/j.ejpb.2012.04.007. Epub 2012 Apr 26. Eur J Pharm Biopharm. 2012. PMID: 22561955 Review.
-
Lipid and polymer nanoparticles for drug delivery to bacterial biofilms.J Control Release. 2014 Sep 28;190:607-23. doi: 10.1016/j.jconrel.2014.03.055. Epub 2014 Apr 30. J Control Release. 2014. PMID: 24794896 Review.
Cited by
-
Chitosan-Coated Liposome Formulations for Encapsulation of Ciprofloxacin and Etoposide.Pharmaceutics. 2024 Aug 2;16(8):1036. doi: 10.3390/pharmaceutics16081036. Pharmaceutics. 2024. PMID: 39204381 Free PMC article.
-
Impediment of selenite-induced cataract in rats by combinatorial drug laden liposomal preparation.Libyan J Med. 2019 Dec;14(1):1548252. doi: 10.1080/19932820.2018.1548252. Libyan J Med. 2019. PMID: 30460877 Free PMC article.
-
Ophthalmic Drug Delivery Systems for Antibiotherapy-A Review.Pharmaceutics. 2018 Jan 13;10(1):10. doi: 10.3390/pharmaceutics10010010. Pharmaceutics. 2018. PMID: 29342879 Free PMC article. Review.
-
Nanovesicular Drug Delivery Systems for Rare Ocular Diseases: Advances, Challenges, and Future Directions.AAPS PharmSciTech. 2025 Jul 23;26(7):197. doi: 10.1208/s12249-025-03159-8. AAPS PharmSciTech. 2025. PMID: 40702295 Review.
-
Potential Therapeutic Usage of Nanomedicine for Glaucoma Treatment.Int J Nanomedicine. 2020 Aug 6;15:5745-5765. doi: 10.2147/IJN.S254792. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32821099 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical